The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was ...
Richard Pazdur, the US Food and Drug Administration’s lead drug regulator, plans to retire from the agency only weeks after ...
Top drug regulator Richard Pazdur filed papers to retire from the Food and Drug Administration at the end of this month, but ...
Rick Pazdur had clashed with Trump officials on the legality and pace of their initiatives. He could still withdraw his ...
The U.S. Food and Drug Administration's newly appointed head of the drug evaluation department, Richard Pazdur, is set to ...
Longtime FDA oncology leader and newly appointed Center for Drug Evaluation and Research director Richard Pazdur has filed ...
The top drug regulator at the Food and Drug Administration, Richard Pazdur, has decided to retire from the agency just three ...
Mere weeks after being named the nation’s top drug regulator, Richard Pazdur, M.D., is taking steps to retire as head of the FDA’s Center for Drug Evaluation and Research at the end of this month, | ...
Weeks after being named head of CDER, Pazdur has submitted paperwork to step down at the end of the month, exacerbating ...
8h
FDA drug chief Pazdur felt undercut by Marty Makary in lead-up to resignation: Peter Pitts | CUOMO
Peter Pitts, a former associate commissioner of the FDA, joins "CUOMO" to discuss the resignation of Dr. Richard Pazdur, the ...
Long-serving FDA figure Richard Pazdur has filed papers to retire, shortly after being appointed to lead the agency's Center ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback